EGFR Inhibitors: Driving Innovation in Targeted Cancer Therapies

agregó una foto Health

2025-09-24 13:14:58

Introduction The rise of precision oncology has reshaped cancer treatment, with one of the most significant milestones being the development of therapies within the EGFR inhibitors Market. By focusing on the epidermal growth factor receptor, scientists and clinicians have expanded treatment options beyond conventional chemotherapy. This therapeutic class has become an integral part of...

0 Commentarios 0 Acciones 631 Views 0 Vista previa